Correlation Between Personalis and Exagen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Personalis and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Personalis and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Personalis and Exagen Inc, you can compare the effects of market volatilities on Personalis and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Personalis with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Personalis and Exagen.

Diversification Opportunities for Personalis and Exagen

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between Personalis and Exagen is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Personalis and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and Personalis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Personalis are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of Personalis i.e., Personalis and Exagen go up and down completely randomly.

Pair Corralation between Personalis and Exagen

Given the investment horizon of 90 days Personalis is expected to under-perform the Exagen. But the stock apears to be less risky and, when comparing its historical volatility, Personalis is 1.4 times less risky than Exagen. The stock trades about -0.11 of its potential returns per unit of risk. The Exagen Inc is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  428.00  in Exagen Inc on December 30, 2024 and sell it today you would lose (44.00) from holding Exagen Inc or give up 10.28% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Personalis  vs.  Exagen Inc

 Performance 
       Timeline  
Personalis 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Personalis has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Exagen Inc 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Exagen Inc are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Exagen may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Personalis and Exagen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Personalis and Exagen

The main advantage of trading using opposite Personalis and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Personalis position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.
The idea behind Personalis and Exagen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device